secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001140361-23-024768
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 5.07, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion announces 1-for-20 reverse stock split effective May 15, reduces shares to ~2.18M
--------------------------------------------------------------------------------

- 1-for-20 reverse split effective 5:00 PM ET May 15; trading begins split-adjusted May 16 under symbol CYCN.
- Post-split outstanding shares approximately 2,176,244; fractional shares paid at $0.2232 per share.
- Stockholders approved reverse split at annual meeting: 29,493,422 for, 2,912,129 against, 45,310 abstain.
- All outstanding options, warrants, and RSUs proportionately adjusted; no change in authorized shares or par value.
- Directors elected and Ernst & Young ratified as independent auditor for fiscal year 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000114036123024768/0001140361-23-024768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000114036123024768/brhc20052986_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-024768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer